-
2016-03-17
上海由国家新药筛选中心主办的 2016年皇后镇分子生物学(上海)会议于2016-03-17在中国金融信息中心举办。
首页>演讲嘉宾> Bo Wiinberg更新时间:2016-03-17
Bo Wiinberg Director of Novo Nordisk A/S, Copenhagen, Denmark. Bringing the next generation medicines and medical innovations to patients. His overall leadership goal has been to build high-performing, collaborative and coherent R&D units with a strong sense of purpose, which deliver more than expected, continuously develop and have the ability to repeatedly push boundaries and quickly adapt to change. Key Competencies: Strong and broad scientific background; In-depth understanding & experience with pharma R&D; strategy, processes and operations, pre clinical (PK/PD/bioanalysis) development, lead candidate selection and filing process; Strategic thinker; strong analytical and problem solving skills and business acumen, with experience in working with/presenting to senior executives ; Leader; driving complex matrix teams with high and consistent level of excellence in strategy development, project management, operations and outcomes; Motivator; setting a clear and relevant direction and targets, with emphasis on purpose and transparency, ensuring both a challenging and motivating working environment; Networker; developing strategic alliances with key internal as well as external individuals, groups and organisations that can improve or accelerate key knowledge, processes or deliveries; Reliable; accountable, self-motivated, well organized, creative, independent, with strong presentation and communication skills.
Bo Wiinberg出席会议日程
由国家新药筛选中心主办的 2016年皇后镇分子生物学(上海)会议于2016-03-17在中国金融信息中心举办。